MENU
AIM
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
AIM ImmunoTech (AIM) Earnings Date & Reports
AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies... Show more
A.I. Advisor
published Earnings
AIM is expected to report earnings to rise 1,059.42% to -800 cents per share on August 18
Q2'26
Est.
$-8.00
Q1'26
Beat
by $7.31
Q4'25
Beat
by $6.61
Q3'25
Beat
by $6.43
Q2'25
Beat
by $4.32
The last earnings report on May 14 showed earnings per share of -68 cents, beating the estimate of -800 cents. With 7.69M shares outstanding, the current market capitalization sits at 7.51M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders
Industry Biotechnology
Profile
Details
Industry
N/A
Address
2117 SW Highway 484
Phone
+1 352 448-7797
Employees
21
Web
https://www.aimimmuno.com